The growth of this market is mainly attributed to factors, such as the advantages offered by PRP treatment; increasing awareness towards PRP therapies; rising prevalence of musculoskeletal, sports, & orthopedic injuries; and the growing number of cosmetic procedures worldwide.
In addition, increasing PRP treatments and advancing healthcare in emerging economies are likely to offer significant growth opportunities for platelet rich plasma therapy providers.
However, the availability of alternatives for PRP treatment and side-effects associated with PRP is expected to restrain the growth of the platelet rich plasma therapy market to some extent during the forecast period. Moreover, the stringent regulatory framework for PRP use is the major challenging factor observed in this market.
Meticulous Research®, in its latest publication on the PRP therapy market, states that the global market will increase at a CAGR of 12.2% during the forecast period to reach $882.5 million by 2028.
To provide efficient analysis, Meticulous Research® has segmented this market based on Type (Pure Platelet-rich Plasma, Leukocyte-rich PRP, Platelet-rich Fibrin, Leukocyte & Platelet rich Fibrin), Application (Orthopedics and Traumatology, Dermatology and Cosmetology, Rheumatology, Stomatology and Odontology, Ophthalmology, Others), End User (Hospitals and Clinics, Research Institutes), and Geography (North America, Asia-Pacific, Europe, Latin America, and the Middle East & Africa).
Download Free Sample Report Copy Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5218
Scope of the Report:
Platelet Rich Plasma Therapy Market, by Type
- Pure Platelet-rich Plasma
- Leukocyte-rich PRP
- Platelet-rich Fibrin
- Leukocyte & Platelet-rich Fibrin
Platelet Rich Plasma Therapy Market, by Application
- Orthopedics and Traumatology
- Dermatology and Cosmetology
- Rheumatology
- Stomatology and Odontology
- Ophthalmology
- Others
Platelet Rich Plasma Therapy Market, by End User
- Hospitals and Clinics
- Research Institutes
Platelet Rich Plasma Therapy Market, by Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- Japan
- China
- India
- Rest of APAC (RoAPAC)
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM (RoLATAM)
- Middle East & Africa
Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5218
Based on geography, the PRP therapy market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In 2021, North America is estimated to account for the largest share of the global PRP therapy market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The large market share of North America in the PRP therapy market is primarily attributed to the presence of leading PRP providers in the region, a large number of patients suffering from orthopedic problems, the presence of leading PRP manufacturers, support from the government, and rising usage of PRP in cosmetic & dermatologic applications.
Based on type, the global platelet rich plasma therapy market is segmented into pure PRP, leukocyte–rich PRP, pure platelet-rich fibrin, and leukocyte and platelet rich fibrin. In 2021, the pure PRP segment is estimated to account for the largest share of the global platelet rich plasma therapy market. Low probability of side-effects and preferred method for point-of-care therapy over surgical procedures are factors responsible for driving the demand for pure PRP in the market.
Based on application, the platelet rich plasma therapy market is segmented into orthopedics & traumatology, rheumatology, dermatology & cosmetology, ophthalmology, stomatology & odontology, and other applications. In 2021, the orthopedics & traumatology segment is estimated to account for the largest share of the global platelet rich plasma therapy market. PRP therapy accelerates the healing of bone injuries by stimulating osteoblasts. Additionally, the growing number of patients with musculoskeletal injuries globally is expected to drive the demand for PRP for orthopedics and traumatology application in the market.
Based on end user, the global platelet rich plasma therapy market is segmented into hospitals & clinics and research institutes. In 2021, the hospitals & clinics segment is estimated to account for a larger share of the global platelet rich plasma therapy market. The rising number of physicians recommending PRP therapy, ease of procedure, and successful outcomes are some of the factors that attribute to the large market share of this segment.
To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/plasma-therapy-market-5218
The report provides competitive intelligence in terms of financials, growth strategies, product portfolios, and geographical presence on some of the key players in this market, including Arthrex, Inc. (U.S.), DePuy Synthes Inc. (U.S.), Dr PRP USA LLC (U.S.), EmCyte Corporation (U.S.), Exactech Inc. (U.S.), Global Stem Cells Group, Inc. (U.S.), Celling Biosciences, Inc. (U.S.), Terumo Corporation (Japan), Regen Lab SA (Switzerland), Stryker Corporation (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), and Juventix Regenerative Medical LLC (U.S.)
Amidst this crisis, Meticulous Research® is continuously assessing the impact of COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. Let us know if you would like to assess the impact of COVID-19 on any industry here-https://www.meticulousresearch.com/custom-research
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.
Media Contact
Company Name: Meticulous Market Research Pvt Ltd
Contact Person: Khushal Bombe
Email: Send Email
Phone: +1 646-781-8004
Address:1267 Willis St, Ste 200 Redding, California, 96001, U.S.
City: pune
State: maharashtra
Country: United States
Website: www.meticulousresearch.com